The FDA granted regenerative medicine advanced therapy (RMAT) designation to Orca-Q, a second-generation investigational ...

An estimated 8% of Americans live with autoimmune diseases that cause chronic inflammation and damage. Now, a breakthrough ...

The deal is expected to advance its cancer immunotherapy candidate VXM01, which has shown promising results in early studies for glioblastoma and pancreatic cancer. ・Under the agreement, BCME will get ...

Fecal microbiota transplantation is an emerging strategy for modulating the gut microbiome to influence immunotherapy ...

A patient recounts sudden vision changes leading to brain tumor surgery and a switch from immunotherapy to targeted therapy ...

The injection of immunotherapy directly into precancerous oral lesions may reduce risk for progression to cancer and help ...

Pancreatic tumors reprogram immune cells that normally shut down tumor-killing cells, according to a team at Oregon Health & ...

Pancreatic ductal adenocarcinoma is one of the deadliest cancer types, with a five-year survival rate of 13%. There are only ...

Immunotherapy—particularly PD-1 inhibition with cemiplimab—is reshaping CSCC care by expanding into neoadjuvant and adjuvant ...

Dr. David Greenberg outlines bladder cancer staging, BCG, immunotherapy, surgery, quality of life impacts and long-term ...

Lund University. Immunotherapy harnesses the body’s own immune system to fight disease and has great potential, both in ...

When comprehensive tissue next-generation sequencing (NGS) fails, liquid biopsy should be the reflex strategy, especially in ...